摘要:The paper discusses the particular problems marketing practice encounters in the pharmaceutical sector, investigating some of their underlying causes. The span of the pharmaceutical sector is then restricted to veterinary pharmaceutical marketing, as a domain in which not the clients themselves are targeted, but their physicians and owners, which are to decide on their behalf. If pharmaceutical marketing, in general, is to be doomed as manipulation, which would be the implications of marketing pharmaceutical products to third parties, with no consent from the beneficiary? The marketing tools and marketing contexts will be analyzed, in an attempt to estimate the efficiency of various approaches.